Apollon Formularies (AQSE:APOL) Median PS Value : £0.00 (As of Jun. 06, 2024)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Apollon Formularies's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was £0. Apollon Formularies's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is £0.00.

As of today (2024-06-06), Apollon Formularies's share price is £8.0E-5. Apollon Formularies's Median PS Value is £0.00. Therefore, Apollon Formularies's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Apollon Formularies's Median PS Value or its related term are showing as below:

AQSE:APOL's Price-to-Median-PS-Value is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.805
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Apollon Formularies Median PS Value Historical Data

The historical data trend for Apollon Formularies's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Median PS Value Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Median PS Value

Get a 7-Day Free Trial

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Median PS Value	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Apollon Formularies's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Price-to-Median-PS-Value falls into.

Apollon Formularies Median PS Value Calculation

Apollon Formularies's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0	*
	=	0.00

10-Year Median PS Ratio is .
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apollon Formularies's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.

Apollon Formularies (AQSE:APOL) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Apollon Formularies's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	8.0E-5	/	0.00
	=

Apollon Formularies Median PS Value Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.